Interest in neprilysin has been revived in recent years with the development of ARNI and the groundbreaking results of PARADIGM-HF (Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial) [49]. The gene discussed is MME; the disease is heart failure.